Label: GUAIFENESIN 200MG- guaifenesin tablet
- NDC Code(s): 69517-148-03
- Packager: HEALTHLIFE OF USA LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated October 21, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each tablet)
- Purpose
- Uses
-
Warnings
Ask a doctor before use if you have
- Persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- Cough accompanied by too much phlegm (mucus)
- Persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- Directions:
- Other Information:
- Inactive Ingredients:
- Questions or comments?
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
GUAIFENESIN 200MG
guaifenesin tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:69517-148 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 200 mg Inactive Ingredients Ingredient Name Strength SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) MAGNESIUM STEARATE (UNII: 70097M6I30) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) Product Characteristics Color white Score no score Shape ROUND Size 8mm Flavor Imprint Code G2 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:69517-148-03 300 in 1 BOTTLE; Type 0: Not a Combination Product 01/28/2022 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M012 01/28/2022 Labeler - HEALTHLIFE OF USA LLC (079656178) Establishment Name Address ID/FEI Business Operations Health Pharma USA LLC 080804485 manufacture(69517-148)